Role of Prostate Specific Antigen Density for the Prediction of Radical Therapy Requirement in Localized Prostate Cancer
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 3
Abstract
Objective: Prostate specific antigen (PSA) PSA density (dPSA) is a PSA derivative used for increasing the accuracy of PSA. dPSA is calculated by dividing the prostate volume measured with transrectal ultrasonography by the total PSA value. In this study, we evaluated the role of dPSA in the prediction of radical therapy requirement in localised prostate cancer. Materials and Methods: A total of 398 patients, who underwent radical prostatectomy in our department, were included in the study. Preoperative data of the patients (demographic data, total PSA, prostate volume, dPSA and tumor percent IE on biopsy) were evaluated retrospectively. D’Amico risk stratification was performed according to the radical prostatectomy pathological examination. Evaluated parameters were compared between low-risk group (Group 1), who were candidates for active surveillance, and intermediate-high-risk group (Group 2) who were candidates for radical therapies. A dPSA cut-off value was investigated for the prediction of radical therapy requirement for patients with ROC curve analysis. Results: Mean age of the patients was similar between the two groups (62.6±6.6 vs. 62.6±58; p=0.999). PSA (8.9±6.9 vs. 5.5±1.5; p<0.05), dPSA (0.19±0.1 vs. 0.08±0.03; p<0.05) and tumor percent on biopsy (40.8±32.6 vs. 10.7±11.7; p<0.05) were significantly higher in Group 2 when compared to Group 1. ROC curve analysis revealed that patients with a dPSA value higher than 0.10 were more likely to have intermediate-high-risk disease according to postoperative the D’Amico risk stratification with 71% sensitivity and 86% specificity (AUC=0.782). Conclusion: As a result, it has been shown that a significant portion of patients with a dPSA level of ≥0.1 was included in the intermediate-high-risk group requiring radical therapies according to the postoperative pathological results. We suggest that predictive models including dPSA would better help decide for active surveillance.
Authors and Affiliations
Ozan Bozkurt, Kaan Çömez, Özgür Gürboğa, Ömer Demir, Güven Aslan, Adil Esen
Keywords
Related Articles
- EP ID EP228298
- DOI 10.4274/uob.701
- Views 126
- Downloads 0
Risk Factors for Adrenal Invasion in Renal Cell Carcinoma
Objective: In this study, we aimed to describe the risk factors associated with adrenal invasion in patients who were diagnosed with renal cell carcinoma (RCC) after radical nephrectomy and identify which risk factors ar...
Current Status of Oligometastatic Prostate Cancer: Risk Factors and Treatment Approaches
Prostate cancer (PCa) is a common disease that causes significant mortality rates. The widespread use of more sophisticated imaging methods has led to the identification of oligometastatic PCa, which has a limited number...
A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
In recent years, studies have been reported about the combination of androgen deprivation therapy (ADT) and different chemotherapy modalities as the initial therapy in newly-diagnosed patients with hormone-sensitive meta...
Vascular Endothelial Growth Factor and Thrombospondin-1 mRNA Expression in Bladder Tumors: Correlation with Histopathology and Prognosis
Objective: The purpose of this study was to determine genetic expression levels of vascular endothelial growth factor (VEGF) and thrombospondin-1 (TSP-1) in fresh bladder tumor specimens and evaluate their relationship w...
A Rare Presentation of Germ Cell Neoplasia: Persistant Müllerian Duct Syndrome
Persistent Müllerian duct syndrome is a rare form of pseudohermaphroditism. This article is made of two case reports showing malignant transformation. The first case was a 36-year-old male who presented with infertility....